Merck has struck the biggest life sciences M&A deal of 2021 so far. Here are the four key IP-related takeaways.
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Life sciences reporter
@IAM_Alerts Ericsson posts strong licensing quarter as it heads into an all-important renewal with Apple https://t.co/xbbxWFsscH https://t.co/KZpjln1pcM Read more
@IAM_Alerts RT @AMorrisReports: VideoLabs has found it tough to build industry support for its membership model during the covid pandemic and a new dec… Read more
@IAM_Alerts RT @burrisiplaw: We had a wonderful time at @IAM_Alerts Auto IP USA! As always, great insights were shared. We enjoyed seeing familiar face… Read more
@IAM_Alerts RT @IAM_Alerts: This week’s Sunday Supplement is now out, including: Auto IP conflict heats up; Honor nets BlackBerry patents; Unprecedente… Read more